NCT00051545

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5 ug) or Placebo in Prolonging Time to Relapse Following Intended Curative Resection or Percutaneous Ablative Treatment for Hepatocellular Carcinoma

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 608 (planned)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).

Conditions

• Liver Neoplasms

Interventions

Type	Name	Description
DRUG	Seocalcitol

Timeline

• Start date: 1999-11-01
• Completion: 2004-06-01
• First posted: 2003-01-14
• Last updated: 2025-02-25

Locations

5 sites across 5 countries: Canada, France, Italy, Spain, United Kingdom